I don't see any published information on neurotrope.com regarding the oral solution. However there are several 3rd party papers discussing bryostatin oral.
Company stance is it won't be an issue. Not wise to tie up resources at this point when drug will be commercially a synthetic version. Truth is i think there is close to a zero chance we'll remain as our own entity at that point imo
News 
Market Data 
Discover 
